Healthcare Triangle is trading 17.92% down at $1.42 after investors sold the stock following its August 13, 2026 Q2 results. - The company reported significantly larger losses, with a six-month net loss of $10.6 million compared to $3.1 million in 2025. - Operating cash flow was negative $7.7 million, and cash and cash equivalents declined to $1.9 million from $7.6 million at year-end 2025. - This overshadowed strong revenue growth, which rose 158% year over year to $9.19 million.